Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects.

Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME.

Epidemiology. 2012 Sep;23(5):751-61. doi: 10.1097/EDE.0b013e31825fb7a0. Erratum in: Epidemiology. 2012 Nov;23(6):940.

PMID:
22828661
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Bounding the infectiousness effect in vaccine trials.

VanderWeele TJ, Tchetgen Tchetgen EJ.

Epidemiology. 2011 Sep;22(5):686-93. doi: 10.1097/EDE.0b013e31822708d5.

PMID:
21753730
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Causal inference for vaccine effects on infectiousness.

Halloran ME, Hudgens MG.

Int J Biostat. 2012 Jan 6;8(2). pii: /j/ijb.2012.8.issue-2/1557-4679.1354/1557-4679.1354.xml. doi: 10.2202/1557-4679.1354.

PMID:
22499732
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines.

Longini IM Jr, Datta S, Halloran ME.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):440-7.

PMID:
8970471
[PubMed - indexed for MEDLINE]
5.

Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.

Longini IM Jr, Sagatelian K, Rida WN, Halloran ME.

Stat Med. 1998 May 30;17(10):1121-36. Erratum in: Stat Med 1999 Apr 15;18(7):890.

PMID:
9618773
[PubMed - indexed for MEDLINE]
6.

A stochastic model of vaccine trials for endemic infections using group randomization.

Riggs TW, Koopman JS.

Epidemiol Infect. 2004 Oct;132(5):927-38.

PMID:
15473157
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Epidemiologic effects of varicella vaccination.

Halloran ME.

Infect Dis Clin North Am. 1996 Sep;10(3):631-55. Review.

PMID:
8856357
[PubMed - indexed for MEDLINE]
8.

A mapping between interactions and interference: implications for vaccine trials.

VanderWeele TJ, Vandenbroucke JP, Tchetgen EJ, Robins JM.

Epidemiology. 2012 Mar;23(2):285-92. doi: 10.1097/EDE.0b013e318245c4ac. Erratum in: Epidemiology. 2012 May;23(3):507.

PMID:
22317812
[PubMed - indexed for MEDLINE]
9.

Assessing the effect of HIV vaccination on infectiousness.

Rida WN.

Stat Med. 1996 Nov 15-30;15(21-22):2393-404; discussion 2405-12.

PMID:
8931209
[PubMed - indexed for MEDLINE]
10.

Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008521. doi: 10.1002/14651858.CD008521.pub3. Review.

PMID:
23152260
[PubMed - indexed for MEDLINE]
11.

Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy.

Datta S, Halloran ME, Longini IM Jr.

Stat Med. 1998 Jan 30;17(2):185-200.

PMID:
9483728
[PubMed - indexed for MEDLINE]
12.

Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.

Cai B, Small DS, Have TR.

Stat Med. 2011 Jul 10;30(15):1809-24. doi: 10.1002/sim.4241. Epub 2011 Apr 15.

PMID:
21495062
[PubMed - indexed for MEDLINE]
13.

Analytic results on the bias due to nondifferential misclassification of a binary mediator.

Ogburn EL, VanderWeele TJ.

Am J Epidemiol. 2012 Sep 15;176(6):555-61. Epub 2012 Aug 28.

PMID:
22930481
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease.

Koepsell TD, Chi YY, Zhou XH, Lee WW, Ramos EM, Kukull WA.

Neurology. 2007 Nov 6;69(19):1868-72.

PMID:
17984455
[PubMed - indexed for MEDLINE]
15.

Odds ratios for mediation analysis for a dichotomous outcome.

Vanderweele TJ, Vansteelandt S.

Am J Epidemiol. 2010 Dec 15;172(12):1339-48. doi: 10.1093/aje/kwq332. Epub 2010 Oct 29.

PMID:
21036955
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household.

Datta S, Halloran ME, Longini IM Jr.

Biometrics. 1999 Sep;55(3):792-8.

PMID:
11315008
[PubMed - indexed for MEDLINE]
17.

Conditional and unconditional infectiousness effects in vaccine trials.

Chiba Y, Taguri M.

Epidemiology. 2013 Mar;24(2):336-7. doi: 10.1097/EDE.0b013e31828261f5. No abstract available.

PMID:
23377097
[PubMed - indexed for MEDLINE]
18.

Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.

Gilbert PB, Bosch RJ, Hudgens MG.

Biometrics. 2003 Sep;59(3):531-41.

PMID:
14601754
[PubMed - indexed for MEDLINE]
19.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

PMID:
11701102
[PubMed - indexed for MEDLINE]
Free Article
20.

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.

Savović J, Jones H, Altman D, Harris R, Jűni P, Pildal J, Als-Nielsen B, Balk E, Gluud C, Gluud L, Ioannidis J, Schulz K, Beynon R, Welton N, Wood L, Moher D, Deeks J, Sterne J.

Health Technol Assess. 2012 Sep;16(35):1-82. Review.

PMID:
22989478
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk